Accordingly, SIRT1 activation by the polyphenol resveratrol and several small molecules have been shown to provide protection against NAFLD and T2DM in rodent models [253,256], and may be beneficial in human metabolic disease [257]. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.